A Win-Win for forward thinking CROs and patients

According to Dan Stanton of Outsourcing-Pharma, CROs who focus on the patient will have the competitive advantage.  At the Partnerships in Clinical Trials (PCT) conference in Hamburg, Germany, representatives from AstraZeneca, EMD and Bayer discuss how having a...

New clinical trial regulation provides positive outlook for EU

In a recent article on Outsourcing Pharma, Dan Stanton discusses the new EU clinical trial regulation and it’s intention to simplify the approval process in hopes of making the EU more accessible and desirable for clinical research. The new regulation will take action...

Wearable technology and clinical trials: beneficial or problematic?

Wearable technology has been taking over the consumer world for health and fitness, and speculation has grown around the topic of utilizing the devices in clinical trials. First Post Business addressed the idea, along with input from Michael Shanler, research director...

Income differences driving participation in clinical trials?

Mary Engel, writer for Fred Hutch News Service, stated the importance of clinical trials and patient involvement in her recent article. Participation in clinical trials is crucial to the development and success of finding new treatments because they are currently the...

Researchers look into new clinical trial design

Researchers from Princeton University, California Institute of Technology, Harvard School of Public Health and the University of Cambridge are currently testing a new trial design called “two-by-two,” which could potentially provide a better link to a patient’s...